Search for Clinical Trial Results
Inclusion Body Myositis - 28 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis Condition:
Date: 2012-01-23 Interventions: Biological: rAAV1.CMV.huFollistatin344 |
Completed |
Study Name: Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients Condition: Sporadic Inclusion Body Myositis Date: 2013-08-15 Interventions:
|
Active, not recruiting |
Study Name: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis Condition: Inclusion Body Myositis (IBM) Date: 2015-05-13 Interventions:
|
Recruiting |
Study Name: Optimizing Treatment on Idiopathic Inflammatory Myopathies Condition: Idiopathic Inflammatory Myopathies Date: 2017-03-09 Interventions: Drug: Intravenous Infusion Intravenous infusion of follow medicine at disease onset: methyprednisolone a |
Recruiting |
Study Name: A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy Condition: Idiopathic Inflammatory Myopathy Date: 2009-09-03 |
Completed |
Study Name: Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies Condition:
Date: 2017-03-09 Interventions: Other: Physical exercises Physical exercises |
Not yet recruiting |
Study Name: Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study Condition: Sporadic Inclusion Body Myositis Date: 2016-04-06 |
Completed |
Study Name: Immune Abnormalities in Sporadic Inclusion Body Myositis Condition:
Date: 2002-02-07 |
Completed |
Study Name: Alemtuzumab to Treat Sporadic Inclusion Body Myositis Condition: Myositis, Inclusion Body Date: 2004-03-12 Interventions: Drug: Alemtuzumab (Campath) |